Objective: To describe the use of hospital-based services and associat
ed costs over time for HIV-infected individuals by disease stage and y
ear of treatment. Methods: Data on service use were abstracted from in
patient and outpatient case-notes of 459 HIV-infected patients (121 as
ymptomatic and 338 AIDS patients) treated at St Mary's Hospital, Londo
n between 1983 and 1989. Cost estimates were derived from a survey of
the 37 departments involved with HIV-related care. The number and type
of admissions and outpatient visits, referral and discharge venues, n
umber and type of tests and procedures performed, drugs prescribed and
associated costs for the study period were the outcome measures used.
Results: Most patients were homosexual men. At the time of first HIV-
related visit, 80.7% lived in London. Most day cases and planned admis
sions were organized through the outpatient clinic; 31% of emergency a
dmissions were initiated by patients themselves. For people with AIDS
the number of day case admissions increased while planned admissions d
ecreased. There was a marked reduction in the duration of inpatient st
ays, especially for AIDS patients. Costs associated with inpatient car
e decreased concomitantly. The number of outpatient visits for patient
s with symptomatic disease increased, resulting in increased outpatien
t expenditure. Asymptomatic patients had fewer inpatient tests,while o
utpatient tests did not change over time; costs followed similar patte
rns. Mean inpatient and outpatient drug-days prescribed did not change
nor did average inpatient drug-costs although outpatient drug-costs i
ncreased. Inpatient tests performed on symptomatic non-AIDS patients d
ecreased, while mean outpatient tests increased; average costs followe
d similar patterns. Inpatient drug-days prescribed and costs remained
the same, while outpatient drug-days and average drug-costs increased
during the study period. For AIDS patients, the number of inpatient te
sts performed and their average costs decreased but outpatient tests p
erformed increased, though their average costs remained the same. Mean
inpatient drug-days prescribed and average drug-costs decreased, whil
e number of outpatient drug-days prescribed and average drug-costs inc
reased markedly over time. For each disease category, expenditure on a
dmissions and related tests decreased over time, while expenditure on
outpatient visits and drug-costs increased. Conclusions: The shift fro
m an inpatient- to an outpatient-based service has resulted in fewer p
atients being investigated and treated in hospital and more as outpati
ents. This has resulted in a reduction of inpatient-related costs, whi
le outpatient-related costs have increased. The overall contribution o
f drug-costs to the total cost has increased greatly over time. With t
he anticipated advent of new antiviral compounds, the importance of as
certaining their effectiveness as well as their efficacy will become c
rucial.